VT H0032

Department of Corrections must execute memorandums of understanding with opioid treatment programs nearest each correctional facility to provide medication for opioid use disorder (MOUD), including methadone, buprenorphine, and opioid antagonists

Inmates who screen positive for opioid use disorder may elect to commence MOUD if deemed medically necessary, and those already receiving treatment prior to incarceration must be allowed to continue for as long as medically necessary

Individualized reentry plans required for inmates receiving MOUD, including scheduled appointments with community treatment providers, a minimum 7-day medication supply at release, discharge summaries, and case management support for at least 6 months post-release

Department must submit annual reports by January 15 on the number of individuals receiving MOUD by medication type, recidivism rates, cost analysis, and health outcomes at 6 months post-release

Department must submit a plan by January 15, 2026 to obtain federal certification for in-house opioid treatment programs at all correctional facilities; effective date July 1, 2025